drugset / Trial / NCT06437054

Verification of the Efficacy/Safety of the Mixed Drug Injectable Delivery Vehicle for Treating Intractable Hearing Loss

NCT06437054 ↗

RandomizedParallel-groupDouble-blindTreatment

Summary

This study is a prospective, randomized pilot study. To verify an efficacy/safety of the mixed drug injectable delivery vehicle for treating intractable hearing loss. Hearing test, endoscopy of tympanic membrane and CT scans will be conducted after intratympanic treatment for evaluation.

Timeline

Start
2026-12-15
Primary completion
2026-12-15
Completion
2028-09-30

Outcome

Outcome not reported

Stopped (Enrollment): “This study was withdrawn before enrollment due to challenges in participant recruitment. A revised study protocol will be initiated under a new research project.”

Drugs

EvaluationDrugModalityDoseRoute
Subject Hyaluronic Acid Other / unclassified 20 mg Intrathecal
Background Dexamethasone Small molecule 5 mg/ml Intrathecal